Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 28
1.
Life Sci ; 260: 118307, 2020 Nov 01.
Article En | MEDLINE | ID: mdl-32841665

AIM: Liver plays a crucial role in innate immunity reactions. This role predisposes the liver to innate-mediated liver injury when uncontrolled inflammation occurs. In this study, the effect of febuxostat administration on acute liver injury induced by concanavalin A (Con A) injection into mouse eye orbital sinus was studied. MATERIALS AND METHODS: Two doses of febuxostat (10 and 20 mg/kg, orally) were administered either 1 h before or 30 min after the administration of Con A. Febuxostat at a low dose (10 mg/kg) before and after Con A modulated the elevation of serum ALT, liver uric acid, liver myeloperoxidase (MPO), and interleukin-1ß (IL-1ß) induced by Con A. The same dose of febuxostat before Con A also decreased serum total bilirubin and neutrophil infiltration, as evidenced by flow cytometry and histopathological analysis. KEY FINDINGS: Febuxostat at a high dose (20 mg/kg) significantly improved serum ALT, AST, albumin, total bilirubin, liver uric acid, MPO, monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-α), interleukin-4 (IL-4), IL-1ß, and neutrophil infiltration induced by Con A administration. The results of histopathological examination of liver cells paralleled the observed biochemical improvements. Hepatocyte apoptosis as evidenced by immunohistochemical examination of cleaved caspase-3 was markedly decreased in the febuxostat protection and treatment groups, in a dose-dependent manner SIGNIFICANCE: These results indicate that febuxostat, especially at the higher dose, may be an effective inhibitor of immune reactions evoked by Con A administration.


Chemokine CCL2/analysis , Concanavalin A/pharmacokinetics , Febuxostat/administration & dosage , Hepatitis/prevention & control , Interleukin-1beta/analysis , Tumor Necrosis Factor-alpha/analysis , Animals , Apoptosis/drug effects , Caspase 3/analysis , Febuxostat/pharmacology , Hepatitis/immunology , Hepatitis/physiopathology , Liver/chemistry , Liver/pathology , Liver/physiopathology , Male , Mice , Neutrophil Infiltration/drug effects , Neutrophils/drug effects , Neutrophils/pathology , Peroxidase/analysis , Uric Acid/analysis
2.
J Mol Model ; 22(6): 125, 2016 06.
Article En | MEDLINE | ID: mdl-27168200

In this study, the newly synthesized non-centrosymmetric, 4-dimethylamino-3'-isothiocyanatochalcone (PKA) compound was presented. This compound belongs to the chalcone group, and its main purpose is to be used in biomedical imaging as a fluorescence dye. For this reason, the linear and nonlinear properties in solvents of different polarity were thoroughly studied. In accordance with the requirements for a fluorochrome, the PKA compound is characterized by strong absorption, large Stokes' shifts, relatively high fluorescence quantum yields and high nonlinear optical response. Moreover, the isothiocyanate reactive probe was conjugated with Concanavalin A. Conventional fluorescence microscopy imaging of Candida albicans cells incubated with the PKA-Concanavalin A, is presented. The results of this study show that the novel conjugate PKA-Concanavalin A could be a promising new probe for cellular labelling in biological and biomedical research. Graphical abstract Spectroscopic behavior of the PKA dye.


Chalcones/chemistry , Fluorescent Dyes/chemistry , Microscopy, Fluorescence/methods , Spectrometry, Fluorescence/methods , Algorithms , Candida albicans/metabolism , Chalcones/chemical synthesis , Chalcones/pharmacokinetics , Concanavalin A/chemistry , Concanavalin A/pharmacokinetics , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/pharmacokinetics , Models, Chemical , Models, Molecular , Molecular Structure , Solvents/chemistry
3.
J Biomed Nanotechnol ; 8(5): 800-8, 2012 Oct.
Article En | MEDLINE | ID: mdl-22888751

Polyhydroxyalkanoates (PHA) are natural, thermoplastic polyesters and due to their biocompatible and biodegradable properties they are good alternatives for the production of scaffolds for engineered tissues or nanoparticles for drug delivery. As a member of polyhydroxyalkanoate family, polyhydroxybutyrates (PHB) have been widely used as a biomaterial for in vitro and in vivo studies since their mechanical properties are very similar to conventional plastics. By using multi-emulsion technique, iron oxide particles were coated with polyhydroxybutyrate (PHB) polymer synthesized from Alcaligenes eutrophus bacteria and the magnetic carrier system was prepared accordingly. The bare nanoparticles and magnetic nanoparticles were morphologically, structurally and magnetically characterized by using Scanning electron microscope (SEM) and Atomic force microscope (AFM); Fourier Transform Infrared Spectrometry (FTIR), and Electron Spin Resonance (ESR) and Vibrating Sample Magnetometer (VSM) techniques, respectively. Particle size of PHB nanoparticles was determined by Zeta Sizer. It was found that the smallest particles were in the range of 239.43 +/- 5.25 nm in diameter. Concanavalin-A (Con-A) was used for targeting the cancer cells while etoposide was used as drug. Con-A and etoposide were loaded onto the particles. Release studies of etoposide were evaluated and the system was optimized for the further in vivo applications. Finally different formulation magnetic PHB nanoparticles cytotoxicity were evaluated in cell culture studies and used HeLa cell line (cervical cancer cells) as a cancer cells and L929 cells (mouse fibroblast cells) as a non-cancer cell line.


Cell Survival/drug effects , Concanavalin A/pharmacokinetics , Cupriavidus necator/metabolism , Etoposide/administration & dosage , Magnetite Nanoparticles/administration & dosage , Nanocapsules/administration & dosage , Polyhydroxyalkanoates/chemistry , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/chemistry , Concanavalin A/administration & dosage , Concanavalin A/chemistry , HeLa Cells , Humans , Magnetite Nanoparticles/chemistry , Materials Testing , Nanocapsules/chemistry , Nanospheres/administration & dosage , Nanospheres/chemistry , Prohibitins
4.
An. R. Acad. Farm ; 74(3): 325-344, jul. 2008. ilus
Article Es | IBECS | ID: ibc-67774

La ruta mTOR/S6K1 controla diferentes funciones celulares entre las quese encuentran la proliferación y el crecimiento de la masa celular. La insulina,IGF-I y EGF son factores de supervivencia de los hepatocitos. En las rutas deseñalización mediadas por sus receptores, todos ellos de la superfamilia tirosinaquinasa, la proteína S6K1 resulta activada. El objetivo de este trabajo ha sidoinvestigar si la deficiencia en S6K1 tiene consecuencias en el equilibrio entre lasupervivencia y la muerte celular en el hígado. Para ello, hemos generado líneas celulares de hepatocitos inmortalizados a partir de hígados de ratones neonatos degenotipo salvaje (S6K1+/+) y deficientes en S6K1 (S6K1–/–). Dichas células se hansometido a dos protocolos de inducción de muerte celular por apoptosis: activaciónde receptores de muerte (TNFR y Fas) y retirada de factores tróficos delmedio de cultivo. Nuestros resultados indican que la falta de S6K1 confiere protecciónfrente a la apoptosis inducida por activación de receptores de muerte. Estefenómeno se debe a que la expresión de la proteína pro-apoptótica Bid está disminuida,la caspasa-8 no se activa y no se produce la degradación de FLIP ni truncamientode Bid en respuesta a TNF y Jo2. De hecho, la falta de S6K1 protege deldaño hepático fulminante producido por la inyección de concanavalina A. Asimismo,la pérdida de S6K1 en los hepatocitos evita la apoptosis inducida por la retiradade factores tróficos. Esto es debido a que en ausencia de S6K1 no se iniciala retroalimentación negativa mediada por la actividad serina quinasa de esta proteínay, en consecuencia, los hepatocitos S6K1–/– mantienen activada la ruta IRS-1/PI3-quinasa que conduce a la activación de las quinasas Akt y ERK que mantienenla supervivencia celular. Nuestros resultados sugieren que la resistencia de loshepatocitos deficientes en S6K1 a la muerte celular por apoptosis podría explicarla resistencia a los compuestos inhibidores de mTOR en el tratamiento de diferentestipos de cáncer, como el hepatocarcinoma


The mTOR/S6K1 signaling pathway controls proliferation and cell growth.Insulin, IGF-I, EGF are trophic factors that elicit survival effects in hepatocytes.These molecules activate mTOR/S6K1 by acting through tyrosine kinase receptors.The aim of this study was to investigate whether S6K1 deficiency alters the balancesurvival/cell death in hepatocytes. For this goal, we have generated immortalizedhepatocyte cell lines from neonatal wild-type and S6K1–/– deficient mice. Apoptosishas been induced in these cells by activating the death receptor pathway or,alternatively, by growth factors deprivation. Our results indicate that the lack ofS6K1 in hepatocytes protects from apoptosis induced by the activation of deathreceptors (TNFR and Fas). In fact, in S6K1–/– hepatocytes the pro-apoptotic proteinBid is down-regulated and its active proteolitic fragment is absent in responseto TNF or Jo2. Moreover, neither caspase-8 is activated nor FLIP is degradedupon TNF or Jo2 treatment. In vivo, S6K1-deficient mice are protected againstConcanavalin A-induced hepatic failure. Deprivation of growth factors inducesapoptosis in wild-type, but not in S6K1–/– hepatocytes. This is due to the lack ofthe negative feed-back that increases IRS-1 serine phosphorylation and inhibitsPI3-kinase/Akt and MAPK survival molecular pathways. Consequently, there is asustained activation of Akt and MAPK in the absence of trophic factors and S6K1-deficient hepatocytes are protected from apoptosis. The molecular mechanisms bywhich S6K1 deficiency protects hepatocytes from apoptosis could be related withthe resistance of some mTOR inhibitors in cancer therapies


Cell Death/physiology , Hepatocyte Growth Factor/physiology , Cellular Apoptosis Susceptibility Protein/pharmacology , Lymphotoxin-alpha/chemical synthesis , Lymphotoxin-alpha/pharmacology , Lymphotoxin-alpha/pharmacokinetics , Tumor Necrosis Factor-alpha/pharmacology , Concanavalin A/pharmacology , Fluorescent Antibody Technique, Direct , Microscopy, Confocal , Hepatocyte Growth Factor/biosynthesis , Hepatocyte Growth Factor/pharmacology , Hepatocyte Growth Factor/pharmacokinetics , Tumor Necrosis Factor-alpha/pharmacokinetics , Concanavalin A/pharmacokinetics
5.
Mol Cell Neurosci ; 33(4): 358-70, 2006 Dec.
Article En | MEDLINE | ID: mdl-17011207

The pore domains of ionotropic glutamate receptors (iGluRs) and potassium channels (K(+) channels) show several structural similarities. To test for functional compatibility, we transferred pore regions from prokaryotic, invertebrate, and vertebrate K(+) channels into pharmacologically representative iGluRs and vice versa. Although the chimeric proteins were expressed on the cell surface, only one of 45 pore chimeras showed ion channel function: The kainate receptor subunit GluR6, carrying the pore loop plus adjacent transmembrane domains of the prokaryotic, glutamate-gated, K(+)-selective GluR0, adopted several electrophysiological properties of the donor pore upon pore transplantation. This suggests that, despite structural similarities between iGluR and K(+) channel pores, there is a lack of functional compatibility so that K(+) channel pores cannot be gated by the iGluR gating machinery, and vice versa. However, K(+)-selective pores can be gated in an iGluR sequence environment, given a similar signal transduction mechanism as appears to be present in GluR0.


Ion Channel Gating/physiology , Potassium Channels/physiology , Receptors, Glutamate/physiology , Animals , Biotinylation/methods , Blotting, Western/methods , Cell Line , Concanavalin A/pharmacokinetics , Dose-Response Relationship, Radiation , Electric Stimulation/methods , Glutamic Acid/pharmacology , Green Fluorescent Proteins/metabolism , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/radiation effects , Kainic Acid/pharmacology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Mutagenesis/physiology , Mutant Chimeric Proteins/physiology , Oocytes , Patch-Clamp Techniques/methods , Potassium Channels/chemistry , Protein Structure, Tertiary/physiology , Rats , Receptors, Glutamate/chemistry , Transfection , Xenopus
6.
J Biomed Opt ; 11(3): 34015, 2006.
Article En | MEDLINE | ID: mdl-16822065

Fluorescence resonance energy transfer (FRET) has become a widely used spectroscopic tool for detecting molecular interactions and molecular proximity in solution, as well as in membranes. On the other hand, fluorescence polarization (FP) is a convenient measure: ratiometric and simple to execute. This work presents a novel methodology for determining energy transfer efficiency (E) via FP measurement. The methodology is based on the fact that a donor's fluorescence lifetime is shortened due to FRET and, consequently, its FP increases. As a model, the present work evaluates the E between fluorescein and rhodamine conjugated ConA attached to the receptors in the lymphocyte membrane. It shows not only that FRET imaging via FP is possible, but also that it is inexpensive, simple to perform, conveniently adaptable to the commonly used fluorescent microscopy, and readily interpretable.


Concanavalin A/pharmacokinetics , Fluorescence Resonance Energy Transfer/methods , Image Interpretation, Computer-Assisted/methods , Microscopy, Fluorescence/methods , Microscopy, Polarization/methods , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Cell Line , Humans
7.
J Bacteriol ; 187(6): 1913-22, 2005 Mar.
Article En | MEDLINE | ID: mdl-15743937

In bacteria, several physiological processes once thought to be the products of uniformly dispersed reactions are now known to be highly asymmetric, with some exhibiting interesting geometric localizations. In particular, the cell envelope of Escherichia coli displays a form of subcellular differentiation in which peptidoglycan and outer membrane proteins at the cell poles remain stable for generations while material in the lateral walls is diluted by growth and turnover. To determine if material in the side walls was organized in any way, we labeled outer membrane proteins with succinimidyl ester-linked fluorescent dyes and then grew the stained cells in the absence of dye. Labeled proteins were not evenly dispersed in the envelope but instead appeared as helical ribbons that wrapped around the outside of the cell. By staining the O8 surface antigen of E. coli 2443 with a fluorescent derivative of concanavalin A, we observed a similar helical organization for the lipopolysaccharide (LPS) component of the outer membrane. Fluorescence recovery after photobleaching indicated that some of the outer membrane proteins remained freely diffusible in the side walls and could also diffuse into polar domains. On the other hand, the LPS O antigen was virtually immobile. Thus, the outer membrane of E. coli has a defined in vivo organization in which a subfraction of proteins and LPS are embedded in stable domains at the poles and along one or more helical ribbons that span the length of this gram-negative rod.


Bacterial Outer Membrane Proteins/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Lipopolysaccharides/pharmacokinetics , Bacterial Outer Membrane Proteins/analysis , Cell Membrane/chemistry , Cell Membrane/metabolism , Concanavalin A/pharmacokinetics , Diffusion , Escherichia coli/chemistry , Escherichia coli Proteins/analysis , Fluorescence Recovery After Photobleaching , Microscopy, Fluorescence , O Antigens/metabolism , Peptidoglycan/metabolism , Protein Binding
8.
J Lab Clin Med ; 143(3): 169-74, 2004 Mar.
Article En | MEDLINE | ID: mdl-15007307

Expression of decay-accelerating factor (DAF, CD55), a complement-regulatory glycoprotein, is enhanced in colorectal-cancer (CC) cells and colonic epithelium in ulcerative colitis (UC), and stools from these patients contain increased amounts of DAF. Carbohydrate chains of glycoproteins are often altered during malignant transformation or inflammation. In this study, we investigated whether DAF molecules in patients with CC and those with UC differ with respect to oligosaccharide side chains. We analyzed DAF in stools and homogenates of colonic-tissue specimens obtained from patients with CC or UC using solid-phase enzyme-linked assay and Western blotting for reactivity with the lectins Ulex europaeus agglutinin I (UEA-I), wheat-germ agglutinin, peanut agglutinin, and concanavalin A. UEA-I bound to DAF in stools from patients with UC but not in that from the stools of CC patients, as demonstrated on the solid-phase enzyme-linked assay (P <.05, Mann-Whitney U test) and Western blotting. Binding of UEA-I was specifically inhibited by the addition of fucose. The difference in UEA-I reactivity with DAF was observed also in colonic-tissue homogenates from patients with UC and those with CC. DAF expressed in the mucosa and excreted into the stools of UC patients is different from that expressed in CC with regard to UEA-I reactivity. Future studies should be directed toward determining whether a qualitatively unique isoform of DAF is present, of which sugar chains are specific to CC in UC patients.


CD55 Antigens/metabolism , Colitis, Ulcerative/immunology , Colonic Neoplasms/immunology , Colorectal Neoplasms/immunology , Feces/chemistry , Plant Lectins/pharmacokinetics , Rectal Neoplasms/immunology , Adenocarcinoma/immunology , Adult , Aged , CD55 Antigens/analysis , Colon/immunology , Colonic Neoplasms/pathology , Colorectal Neoplasms/pathology , Concanavalin A/pharmacokinetics , Female , Humans , Intestinal Mucosa/immunology , Kinetics , Lectins/pharmacokinetics , Male , Middle Aged , Neoplasm Staging , Plant Lectins/analysis , Rectal Neoplasms/pathology
9.
Biotechnol Bioeng ; 82(5): 506-16, 2003 Jun 05.
Article En | MEDLINE | ID: mdl-12652474

The use of fluidizable affinity adsorbents for the adsorption of cells in expanded mode is investigated. Affinity adsorbents have been synthesized by immobilizing the lectin Concanavalin A onto the surface of triazine-activated perfluorocarbon-solids. The adsorbents were found to adsorb Saccharomyces cerevisiae cells from solution with adsorption capacities of up to 6.8 x 10(9) cells mL(-1). Adsorption kinetics were rapid with a time constant of

Bacterial Adhesion/physiology , Cell Separation/methods , Chromatography, Affinity/methods , Concanavalin A/analogs & derivatives , Concanavalin A/pharmacokinetics , Saccharomyces cerevisiae/isolation & purification , Saccharomyces cerevisiae/metabolism , Adsorption , Cell Count , Cell Separation/instrumentation , Chromatography, Affinity/instrumentation , Concanavalin A/chemical synthesis , Enzymes, Immobilized/pharmacokinetics , Fluorocarbons/chemical synthesis , Fluorocarbons/chemistry , Fluorocarbons/pharmacokinetics , Membranes, Artificial , Saccharomyces cerevisiae/cytology
10.
Int J Biol Macromol ; 30(5): 251-8, 2002 Oct 01.
Article En | MEDLINE | ID: mdl-12297232

Two natural glycoproteins/glycoenzymes, invertase and glucoamylase, and two neoglycoconjugates, synthetized from Saccharomyces cerevisiae mannan, bovine serum albumin and penicillin G acylase were tested for interaction with lectin Concanavalin A (Con A). The interaction of natural and synthetic glycoproteins with Con A was studied using three different experimental methods: (i). quantitative precipitation in solution (ii). sorption to Con A immobilized on bead cellulose; and (iii). kinetic measurement of the interaction by surface plasmon resonance. Prepared neoglycoproteins were further characterized: saccharide content, molecular weight, polydispersion, kinetic and equilibrium association constants with Con A were determined. It can be concluded that the used conjugation method proved to be able to produce neoglycoproteins with similar properties like natural glycoproteins, i.e. enzymatic activity (protein part) and lectin binding activity (mannan part) were preserved and the neoglycoconjugates interact with Con A similarly as natural mannan-type glycoproteins.


Concanavalin A/pharmacokinetics , Glycoproteins/chemistry , Mannans/chemistry , Aspergillus niger/enzymology , Binding Sites , Epitopes/chemistry , Epitopes/metabolism , Glucan 1,4-alpha-Glucosidase/metabolism , Glycoconjugates/chemistry , Glycoconjugates/metabolism , Glycoproteins/isolation & purification , Glycoproteins/metabolism , Glycoside Hydrolases/metabolism , Glycosylation , Mannans/metabolism , Penicillin Amidase/metabolism , Saccharomyces cerevisiae , beta-Fructofuranosidase
11.
FEBS Lett ; 525(1-3): 29-32, 2002 Aug 14.
Article En | MEDLINE | ID: mdl-12163156

Studies of [3H]glycerol turnover in phosphatidylcholine (PC) in platelets revealed two metabolic pools, a 'low turnover PC' in collagen-induced microparticles with specific radioactivity only 10% of that found in the 'high turnover PC' of bulk platelet PC. Isolated organelle fractions of [3H]glycerol-labelled platelets contained [3H]PC with specific radioactivities about 20% of that in membrane fractions. These results together with studies on distribution of concanavalin A-FITC and GPlb, a plasma membrane receptor, indicate that microparticles formed during exocytosis are not simple vesiculations of plasma membrane, but they seem rather to originate from a relatively metabolically static membrane pool not accessible to extracellular reagents.


Blood Platelets/chemistry , Cell Membrane/chemistry , Exocytosis/physiology , Fluorescein-5-isothiocyanate/analogs & derivatives , Organelles/chemistry , Blood Platelets/metabolism , Cell Membrane/metabolism , Concanavalin A/pharmacokinetics , Flow Cytometry , Fluorescein-5-isothiocyanate/pharmacokinetics , Fluorescent Dyes/pharmacokinetics , Glycerol/chemistry , Glycerol/metabolism , Humans , L-Lactate Dehydrogenase/analysis , L-Lactate Dehydrogenase/metabolism , Organelles/metabolism , Phosphatidylcholines/chemistry , Phosphatidylcholines/metabolism , Platelet Glycoprotein GPIb-IX Complex/analysis , Platelet Glycoprotein GPIb-IX Complex/metabolism , Subcellular Fractions/chemistry , Tritium
12.
J Neurosci Res ; 65(5): 378-86, 2001 Sep 01.
Article En | MEDLINE | ID: mdl-11536320

We investigated the role of kainate (KA) receptor activation and desensitization in inducing the increase in the intracellular free Ca(2+) concentration ([Ca(2+)](i)) in individual cultured rat hippocampal neurons. The rat hippocampal neurons in the cultures were shown to express kainate receptor subunits, KA2 and GluR6/7, either by immunocytochemistry or by immunoblot analysis. The effect of LY303070, an alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA) receptor antagonist, on the alterations in the [Ca(2+)](i) caused by kainate showed cell-to-cell variability. The [Ca(2+)](i) increase caused by kainate was mostly mediated by the activation of AMPA receptors because LY303070 inhibited the response to kainate in a high percentage of neurons. The response to kainate was potentiated by concanavalin A (Con A), which inhibits kainate receptor desensitization, in 82.1% of the neurons, and this potentiation was not reversed by LY303070 in about 38% of the neurons. Also, upon stimulation of the cells with 4-methylglutamate (MGA), a selective kainate receptor agonist, in the presence of Con A, it was possible to observe [Ca(2+)](i) changes induced by kainate receptor activation, because LY303070 did not inhibit the response in all neurons analyzed. In toxicity studies, cultured rat hippocampal neurons were exposed to the drugs for 30 min, and the cell viability was evaluated at 24 hr using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The selective activation of kainate receptors with MGA, in the presence of Con A, induced a toxic effect, which was not prevented by LY303070, revealing a contribution of a small subpopulation of neurons expressing kainate receptors that independently mediate cytotoxicity. Taken together, these results indicate that cultured hippocampal neurons express not only AMPA receptors, but also kainate receptors, which can modulate the [Ca(2+)](i) and toxicity.


Calcium Signaling/drug effects , Calcium/metabolism , Cells, Cultured/drug effects , Hippocampus/drug effects , Neurons/drug effects , Receptors, AMPA/drug effects , Receptors, Kainic Acid/drug effects , Animals , Benzodiazepines/pharmacology , Calcium Signaling/physiology , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured/cytology , Cells, Cultured/metabolism , Chelating Agents/pharmacokinetics , Concanavalin A/pharmacokinetics , Excitatory Amino Acid Antagonists/pharmacology , Fetus , Fura-2/pharmacokinetics , Glutamates/pharmacology , Hippocampus/cytology , Hippocampus/metabolism , Immunohistochemistry , Kainic Acid/pharmacology , Microscopy, Confocal , Microtubule-Associated Proteins/metabolism , Neurons/cytology , Neurons/metabolism , Neurotoxins/metabolism , Neurotoxins/pharmacology , Rats , Rats, Wistar , Receptors, AMPA/metabolism , Receptors, Kainic Acid/metabolism , Tetrazolium Salts , Thiazoles , GluK3 Kainate Receptor
13.
Cancer Detect Prev ; 24(1): 100-6, 2000.
Article En | MEDLINE | ID: mdl-10757129

The jack bean lectin, concanavalin A (Con A), was modified with 2,4-bis[O-methoxypoly(ethylene glycol)]-6-chloro-s-triazine, activated PEG2, to form PEG-Con A. The immunoreactivity of PEG-Con A towards anti-Con A antibodies was reduced by increasing the degree of modification of amino groups in the Con A molecule. PEG-Con A had a complete reduction of the immunogenicity in mice and prolonged the clearance-time in blood. Although the mitogenic activity of Con A towards murine spleen cells was reduced by the conjugation with activated PEG2, the administration of PEG-Con A to mice enhanced the anti-tumor cytotoxicity of peripheral lymphocytes against melanoma B16 cells.


Concanavalin A/therapeutic use , Melanoma, Experimental/drug therapy , Polyethylene Glycols/therapeutic use , Solvents/therapeutic use , T-Lymphocytes, Cytotoxic/drug effects , Animals , Antibodies, Neoplasm/analysis , Concanavalin A/immunology , Concanavalin A/pharmacokinetics , Drug Combinations , Female , Hemagglutination/drug effects , Immunoglobulin G/immunology , Melanoma, Experimental/blood , Melanoma, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mitosis/drug effects , Polyethylene Glycols/pharmacokinetics , Solvents/pharmacokinetics , Spleen/pathology , T-Lymphocytes, Cytotoxic/pathology , Tumor Cells, Cultured/drug effects
14.
Ophthalmic Res ; 31(4): 267-72, 1999.
Article En | MEDLINE | ID: mdl-10325541

The luminal surface of the rod photoreceptor disk membrane was exposed by means of osmotic shock and labeled with ferritin- conjugated concanavalin A. The structural changes of the luminal surface were examined by a freeze-etching procedure with cryoprotectant (methanol). On replicas from freeze-etched membranes with concanavalin A labeling, 6- to 10-nm particles were codistributed with ferritin particles on the luminal surface of the disk membrane. By contrast, there were few ferritin particles or less numerous 6- to 10-nm particles on the corresponding surface without concanavalin A labeling. If 6- to 10-nm particles corresponded to the carbohydrate moiety of rhodopsin, concanavalin A binding might tend to preserve this carbohydrate moiety. These results suggest that the two-dimensional analysis of lectin-induced structural changes of the membrane surface glycoconjugates may become available by lectin cytochemistry combined with freeze-etching.


Rod Cell Outer Segment/ultrastructure , Animals , Binding Sites/physiology , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Concanavalin A/metabolism , Concanavalin A/pharmacokinetics , Ferritins/metabolism , Freeze Etching , Histocytochemistry , Lampreys , Microscopy, Electron , Particle Size , Rod Cell Outer Segment/metabolism
15.
Poult Sci ; 77(2): 282-9, 1998 Feb.
Article En | MEDLINE | ID: mdl-9495494

An experiment was conducted to investigate the effects of the lectin, Concanavalin A (Con A), contained in raw Jack bean (JB) (Canavalia ensiformis, L.) seeds on the immunological response of broilers. A maize-soybean meal basal diet was prepared to which either 2.5, 5, or 10% of ground raw Jack bean (RJB) seeds was added. The RJB seeds contained 24 g Con A/kg on a dry matter basis, as measured by rocket immunoelectrophoresis. Similar diets were prepared by using the same levels of JB after toasting at 190 C for 16 min. In addition, the basal diet was pair-fed to groups of chicks at the level of feed intake of chicks fed the 10% RJB diet. Each diet was fed to six groups of six chicks for 6 wk. At 5 wk, 15 of chicks from each diet were immunized against Brucella abortus (BA) and the anti-BA antibody titers were determined 1 wk later by ELISA. Antibody production against Con A was also measured by the same method. Binding of Con A to intestinal villi and subsequent endocytosis were confirmed by microscopic examination using a specific peroxidase-antiperoxidase-staining technique. Performance was recorded weekly. Feed intake and weight gain were reduced (P < 0.05) only by the diet containing 10% RJB, indicating that broiler chicks can tolerate daily intakes of 100 mg of Con A over 6 wk without affecting growth. Toasted JB diets supported adequate chick performance. The antibody response to BA did not differ with dietary treatment. Serum from chicks fed raw JB also contained antibodies against Con A. The bursa of Fabricius, thymus, spleen, and pancreas dry weights, as a percentage of dry body weight, were not affected by the experimental diets. The data indicated that Con A binds to the cells of the gastrointestinal tract, passes into the general circulation and, eventually, elicits an immunological response without affecting the production of antibodies to BA.


Antibodies, Bacterial/biosynthesis , Body Weight/drug effects , Chickens/immunology , Concanavalin A/pharmacology , Duodenum/drug effects , Animal Nutritional Physiological Phenomena , Animals , Body Weight/physiology , Brucella Vaccine/immunology , Brucella abortus/immunology , Chickens/physiology , Cohort Studies , Concanavalin A/administration & dosage , Concanavalin A/pharmacokinetics , Duodenum/metabolism , Duodenum/ultrastructure , Eating/physiology , Fabaceae/chemistry , Fabaceae/immunology , Immune Sera/immunology , Immunoglobulin G/immunology , Liver/anatomy & histology , Liver/drug effects , Male , Microvilli/drug effects , Microvilli/ultrastructure , Organ Size/drug effects , Plant Lectins , Plants, Medicinal , Rabbits , Random Allocation , Seeds/chemistry , Seeds/immunology
16.
J Cell Sci ; 108 ( Pt 11): 3611-21, 1995 Nov.
Article En | MEDLINE | ID: mdl-8586672

We have used electron microscopy and flow cytofluorimetry to study endocytosis and intracellular transport of fluid phase bovine serum albumen gold complexes and membrane bound concanavalin A through endosomal compartments of bloodstream forms of Trypanosoma brucei rhodesiense. Both markers were rapidly endocytosed from the flagellar pocket. Within 20 minutes at 37 degrees C the markers reached a large, vesicular, perinuclear compartment that stained heavily with the CB1 monoclonal antibody. Neither marker left the flagellar pocket and entered cells at 4 degrees C. When cells were incubated at 12 degrees C, both markers entered the cell and were transported to collecting tubules, a tubular endosomal compartment that receives endocytosed material from coated endocytic vesicles. However, no material was transported from collecting tubules to the late, perinuclear compartment at 12 degrees C. The morphology of collecting tubule membranes was specifically altered at 12 degrees C; tubules became shorter and were arrayed near the flagellar pocket. The morphological alteration and the block in transport of endocytic markers to the perinuclear compartment seen at 12 degrees C were reversed 10 minutes after cells were returned to 37 degrees C. We also used flow cytofluorimetric measurements of pH dependent fluorescence quenching to measure the pH of the terminal endocytic compartment. Fluoresceinated lectins accumulated in a terminal compartment with a pH of 6.0-6.1, a value considerably higher than that of mammalian lysosomes. Fluorescence from fluoresceinated lectins in this terminal endocytic compartment was dequenched when bloodstream forms were incubated in the presence of chloroquine.


Endosomes/metabolism , Trypanosoma brucei brucei/metabolism , Acids/analysis , Albumins/pharmacokinetics , Animals , Biological Transport/physiology , Biomarkers , Cattle , Cell Compartmentation , Chloroquine/pharmacology , Cold Temperature , Concanavalin A/pharmacokinetics , Endocytosis/physiology , Endosomes/parasitology , Gold/pharmacokinetics , Hot Temperature , Kinetics , Microscopy, Electron , Trypanosoma brucei brucei/ultrastructure
17.
Cancer Res ; 55(17): 3752-6, 1995 Sep 01.
Article En | MEDLINE | ID: mdl-7641188

Molecular size is one of the key determinants of transvascular transport of therapeutic agents in tumors. However, there are no data in the literature on the molecular size dependence of microvascular permeability in tumors. Therefore, we measured microvascular permeability to various macromolecules in the human colon adenocarcinoma LS174T transplanted in dorsal skin chambers in severe combined immunodeficient mice. These molecules were fluorescently labeled and injected i.v. into mice. The microvascular permeability was calculated from the fluorescence intensity measured by the intravital fluorescence microscopy technique. The value of permeability varied approximately 2-fold in the range of molecular weight from 25,000 to 160,000. These data indicate that tumor vessels are less permselective than normal vessels, presumably due to large pores in the vessel wall. The transport of macromolecules appears to be limited by diffusion through these pores. The cutoff size of the pores was estimated by observations of transvascular transport of sterically stabilized liposomes of 100-600 nm in diameter. We found that tumor vessels in our model were permeable to liposomes of up to 400 nm in diameter, suggesting that the cutoff size of the pores is between 400 and 600 nm in diameter.


Capillary Permeability , Neoplasms/blood supply , Animals , Concanavalin A/chemistry , Concanavalin A/pharmacokinetics , Diffusion , Humans , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/metabolism , Immunoglobulin Fc Fragments/chemistry , Immunoglobulin Fc Fragments/metabolism , Immunoglobulin G/chemistry , Immunoglobulin G/metabolism , Liposomes , Mice , Mice, SCID , Molecular Weight , Ovalbumin/chemistry , Ovalbumin/metabolism , Transplantation, Heterologous
18.
Vet. Méx ; 26(2): 113-6, abr.-jun. 1995. ilus, tab
Article Es | LILACS | ID: lil-173880

Se evaluó el efecto de la administración de concanavalina A (Con A) en ratones expuestos a Toxoplasma gondii. Cuarenta y ocho ratones, cepa NIH (hembras de 22 a 24 g), libres de parásitositos, fueron distribuidos al azar en ocho grupos (A1, A2, B1, B2, C1, C2, D1, D2) de seis animales cada uno. Estos, fueron inoculados por vía intraperitoneal (i.p.) de la siguiente manera: los de los grupos A, B y C recibieron 10, 20 y 40 µg de Con A, respectivamente, mientras que los del grupo D recibieron 0.1 ml de solución salina fisiológica. Todos los ratones fueron confrontados por vía i.p. con 2 LD DE T. gondii, cepa RH. Los de los grupos A1, B1, C1 y D1 fueron expuestos al protozoario dos días después del tratamiento; mientras que los de los grupos A2, B2, C2 y D2, siete días después de éste. Los porcentajes de animales sobrevivientes obtenidos 15 días después de la infección, fueron 16.66, 16.66, 0, 0, 33.33, 50, 16.66 y 0 para los grupos A1, B1, C1, D1, A2, B2, C2 y D2, respectivamente. Para corroborar los resultados obtenidos en los últimos cuatro grupos, se repitió el experimento, después del cual se observaron consecuencias similares, excepto que en el grupo tratado con 40 µg de Con A, se obtuvo una sobrevivencia del 33.33 por ciento. Los datos obtenidos indican que la inyección i.p. de Con A en ratones NIH genera una protección parcial insepecífica contra T. gondii cepa RH, la cual aumenta si se aplican 20 µg del mitógeno siete días antes de la confrontación


Mice , Animals , Female , Toxoplasma/immunology , Concanavalin A/pharmacokinetics , Immunity, Innate/drug effects , Mice/parasitology , Mitogens/therapeutic use
19.
Folia Neuropathol ; 33(3): 153-7, 1995.
Article En | MEDLINE | ID: mdl-8705283

Twenty two Mongolian gerbils after 5 min bilateral carotid artery occlusion and 6, 12, 24, 48, 72, 94 hours and 5 days survival were investigated for the neuronal changes in dorsal hippocampus. Paraffin sections were stained with cresyl-violet and marked by their binding of Concanavalin A (Con A) labelled with peroxidase. The degeneration and neuronal loss was observed only in CA1 sectors in almost all experimental groups, whereas the decreased binding of Con A by the neurons of CA1 sector corresponded to the intensity of histologic changes but appeared also only in this sector even without any histological changes. These observation can point at the subthreshold damage of CA1 neurons as result of either diminished supply or increased metabolism of d-glucose, or diminished number of Con A receptors or changes of their specificity after ischemic period.


Binding Sites , Brain Ischemia/physiopathology , Concanavalin A/pharmacokinetics , Hippocampus/metabolism , Hippocampus/physiopathology , Neurons/metabolism , Animals , Gerbillinae , Hippocampus/ultrastructure , Neurons/ultrastructure
20.
Biophys J ; 67(3): 957-65, 1994 Sep.
Article En | MEDLINE | ID: mdl-7811952

Improvements and extended applications of time-resolved delayed luminescence imaging microscopy (TR-DLIM) in cell biology are described. The emission properties of europium ion complexed to a fluorescent chelating group capable of labeling proteins are exploited to provide high contrast images of biotin labeled ligands through detection of the delayed emission. The streptavidin-based macromolecular complex (SBMC) employs streptavidin cross-linked to thyroglobulin multiply labeled with the europium-fluorescent chelate. The fluorescent chelate is efficiently excited with 340-nm light, after which it sensitizes europium ion emission at 612 nm hundreds of microseconds later. The SBMC complex has a high quantum yield orders of magnitude higher than that of eosin, a commonly used delayed luminescent probe, and can be readily seen by the naked eye, even in specimens double-labeled with prompt fluorescent probes. Unlike triplet-state phosphorescent probes, sensitized europium ion emission is insensitive to photobleaching and quenching by molecular oxygen; these properties have been exploited to obtain delayed luminescence images of living cells in aerated medium thus complementing imaging studies using prompt fluorescent probes. Since TR-DLIM has the unique property of rejecting enormous signals that originate from scattered light, autofluorescence, and prompt fluorescence it has been possible to resolve double emission images of living amoeba cells containing an intensely stained lucifer yellow in pinocytosed vesicles and membrane surface-bound SBMC-labeled biotinylated concanavalin A. Images of fixed cells represented in terms of the time decay of the sensitized emission show the lifetime of the europium ion emission is sensitive to the environment in which it is found. Through the coupling of SBMC to streptavidin,a plethora of biotin-based tracer molecules are available for immunocytochemical studies.


Europium , Microscopy/methods , Animals , Bacterial Proteins , Biophysical Phenomena , Biophysics , Concanavalin A/pharmacokinetics , Dictyostelium , Fluorescent Dyes , Immunohistochemistry , Luminescence , Phenanthrolines , Photochemistry , Reproducibility of Results , Streptavidin
...